Found 10 matching trials
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma PHASE1 In this study, investigators are trying to see if LMP specific cytotoxic T ...
Show More Location
Childrens National Medical Center
Learn More & Join Trial
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases PHASE1 Patients have a type of a lymph node cancer called lymphoma, a tumor of the...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma PHASE1 This protocol is broken up into 2 portions to determine the maximum tolerat...
Show More Location
Texas Children's Hospital
Learn More & Join Trial
Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas PHASE1 This trial will use a new method of treating lymphoma using a therapy deriv...
Show More Location
Princess Alexandra Hospital
Learn More & Join Trial
Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder PHASE2 This pilot phase II trial studies how well rituximab and latent membrane pr...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma PHASE1 The administration of allogeneic third party derived LMP specific-CTLs (spe...
Show More Location
Children's National Medical Center
Learn More & Join Trial
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) PHASE1 The subject has a type of cancer or lymph gland disease associated with a v...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma PHASE2 The investigators intend to utilize reduced intensity conditioning and allo...
Show More Location
New York Medical College
Learn More & Join Trial
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE PHASE1 Subjects have a type of lymph gland disease called Hodgkin or non-Hodgkin L...
Show More Location
Harris Health System (includes ben Taub General Hospital and Smith)
Learn More & Join Trial
Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta) PHASE1 Patients have a type of lymph gland cancer called HD, NHL or lymphoepitheli...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial